Novel targeted approaches in non-small cell lung cancer (NSCLC)

Ann Oncol. 2006 May:17 Suppl 5:v91-3. doi: 10.1093/annonc/mdj959.
No abstract available

Publication types

  • Evaluation Study
  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Clinical Trials as Topic
  • Drug Delivery Systems
  • ErbB Receptors / antagonists & inhibitors
  • Humans
  • Lung Neoplasms / drug therapy*

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • EGFR protein, human
  • ErbB Receptors